These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8200940)

  • 21. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercalciuria secondary to chronic hypophosphatemia.
    Navarro JF; Teruel JL; Montalban C; Gallego N; Ortuño J
    Miner Electrolyte Metab; 1994; 20(5):255-8. PubMed ID: 7700212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
    J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects of X-linked hypophosphatemic rickets.
    Chung WT; Niu DM; Lin CY
    Acta Paediatr Taiwan; 2002; 43(1):26-34. PubMed ID: 11890223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro.
    el-Hajj Fuleihan G; Chen CJ; Rivkees SA; Marynick SP; Stock J; Pallotta JA; Brown EM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):860-7. PubMed ID: 2778039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE; Glorieux FH
    Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study.
    Carpenter TO; Keller M; Schwartz D; Mitnick M; Smith C; Ellison A; Carey D; Comite F; Horst R; Travers R; Glorieux FH; Gundberg CM; Poole AR; Insogna KL
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2381-8. PubMed ID: 8964881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ; Kwon SH; Kim SW; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
    Horm Res; 2003; 60(3):127-33. PubMed ID: 12931040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets.
    Hahn TJ; Scharp CR; Halstead LR; Haddad JG; Karl DM; Avioli LV
    J Clin Endocrinol Metab; 1975 Nov; 41(5):926-37. PubMed ID: 1184724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets.
    Seino Y; Shimotsuji T; Ishida M; Ishii T; Yamaoka K; Yabuuchi H
    Contrib Nephrol; 1980; 22():101-6. PubMed ID: 6249540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiopathological aspects of the parathyroid hormone and calcitonin in childhood].
    Tanas R; Turchi S; Platé L; Ciacci L; Ventura D; Pirazzoli P; Cicognani A; Capelli M; Cacciari E
    Minerva Pediatr; 1979 Dec; 31(23):1669-76. PubMed ID: 233430
    [No Abstract]   [Full Text] [Related]  

  • 33. Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism.
    Insogna KL; Mitnick ME; Stewart AF; Burtis WJ; Mallette LE; Broadus AE
    N Engl J Med; 1985 Oct; 313(18):1126-30. PubMed ID: 2995810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study.
    Carpenter TO; Olear EA; Zhang JH; Ellis BK; Simpson CA; Cheng D; Gundberg CM; Insogna KL
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3103-11. PubMed ID: 25029424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets.
    Lewy JE; Cabana EC; Repetto HA; Canterbury JM; Reiss E
    J Pediatr; 1972 Aug; 81(2):294-300. PubMed ID: 4339535
    [No Abstract]   [Full Text] [Related]  

  • 36. Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets.
    Alon U; Lovell HB; Donaldson DL
    Clin Pediatr (Phila); 1992 Mar; 31(3):180-3. PubMed ID: 1547591
    [No Abstract]   [Full Text] [Related]  

  • 37. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW; Binet A; Daneman A
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
    Cundy T; Kanis JA; Heynen G; Earnshaw M; Clemens TL; O'Riordan JL; Merrett AL; Compston JE
    Br Med J (Clin Res Ed); 1982 Mar; 284(6319):883-5. PubMed ID: 6279228
    [No Abstract]   [Full Text] [Related]  

  • 39. Parathyroid hormone sensitivity in familial X-linked hypophosphatemic rickets.
    McElduff A; Posen S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):386-9. PubMed ID: 2753981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.